345 related articles for article (PubMed ID: 18000382)
1. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
2. [Cytogenetic study of 121 patients suffering from various hematologic neoplasms using the in situ hybridization technique].
Pérez Losada A; Solé F; Woessner S; Florensa L; Besses C; Espinet B; Caballín MR; García Eroles L; Sans-Sabrafén J
Sangre (Barc); 1996 Jun; 41(3):201-9. PubMed ID: 8755208
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
4. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
Poppe B; De Paepe A; Speleman F
Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
[TBL] [Abstract][Full Text] [Related]
5. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
6. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics of lymphomas.
Campbell LJ
Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
[TBL] [Abstract][Full Text] [Related]
8. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul RK; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
Cytokines Mol Ther; 1996 Sep; 2(3):163-9. PubMed ID: 9384700
[TBL] [Abstract][Full Text] [Related]
10. [Chromosome analysis and FISH method].
Eguchi M; Tanaka K
Rinsho Byori; 1996 Jun; 44(6):541-7. PubMed ID: 8752732
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions.
Mühlmann M
Genet Mol Res; 2002 Jun; 1(2):117-27. PubMed ID: 14963837
[TBL] [Abstract][Full Text] [Related]
13. Is there an association with constitutional structural chromosomal abnormalities and hematologic neoplastic process? A short review.
Panani AD
Ann Hematol; 2009 Apr; 88(4):293-9. PubMed ID: 19129995
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
[TBL] [Abstract][Full Text] [Related]
15. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
16. Miniaturized FISH for screening of onco-hematological malignancies.
Zanardi A; Bandiera D; Bertolini F; Corsini CA; Gregato G; Milani P; Barborini E; Carbone R
Biotechniques; 2010 Jul; 49(1):497-504. PubMed ID: 20615202
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in fluorescence in situ hybridization (FISH) in hematology.
Berger R
Pathol Biol (Paris); 1995 Mar; 43(3):175-80. PubMed ID: 7675544
[TBL] [Abstract][Full Text] [Related]
18. Interphase FISH as a new tool in tumor pathology.
Tibiletti MG
Cytogenet Genome Res; 2007; 118(2-4):229-36. PubMed ID: 18000375
[TBL] [Abstract][Full Text] [Related]
19. FISH in cancer diagnosis and prognostication: from cause to course of disease.
Weier HU; Greulich-Bode KM; Ito Y; Lersch RA; Fung J
Expert Rev Mol Diagn; 2002 Mar; 2(2):109-19. PubMed ID: 11962331
[TBL] [Abstract][Full Text] [Related]
20. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
